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ABSTRACT
Objective: This study was aimed to evaluate the antioxidant potential of sinapic acid in both in vitro and in vivo. Recently, we have reported that oral 
administration of sinapic acid (3,5-dimethoxy 4-hydroxycinnamic acid) an active phyto ingredient widely distributed in rye, mustard, berries, and 
vegetables has been shown to ameliorate hyperglycemia.
Methods: Experimental Type 2 diabetes was induced in male Wistar rats by feeding high-fat diet to induce insulin resistance followed by intraperitoneal 
administration of a single low dose streptozotocin (35 mg/kg body weight [bw]). Sinapic acid was administered orally at a concentration of 25 mg/kg 
bw/rat/day for 30 days, and its efficacy was compared with metformin. In vitro, antioxidant scavenging properties of sinapic acid were determined 
using 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), superoxide, and nitric oxide (NO) assay.
Results: Sinapic acid treatment showed a significant decline in the levels of lipid peroxides, hydroperoxides and protein carbonyls in the plasma and 
vital tissues of diabetic rats. The treatment also improved the antioxidant status in diabetic rats indicating the antioxidant potential of sinapic acid. 
In addition, the results of DPPH, ABTS, superoxide, and NO radical scavenging assays substantiate the free radical scavenging efficacy of sinapic acid.
Conclusion: The results of this study evidenced that sinapic acid possess significant antioxidant properties which in turn may be responsible for its 
antidiabetic properties.
Keywords: Sinapic acid, High-fat diet-streptozotocin, Oxidative stress, Antioxidant, In vitro antioxidant assay.
INTRODUCTION
Chronic hyperglycemia-induced oxidative stress chiefly contributes to 
the development and progression of diabetes-associated complications. 
Increased oxidative stress appears to be a deleterious factor accounts 
for insulin resistance, dyslipidemia, β-cell dysfunction, impaired 
glucose tolerance, and ultimately the onset of Type 2 diabetes mellitus 
(T2DM). Chronic oxidative stress, hyperglycemia, and dyslipidemia are 
particularly harmful for β-cells due to low availability of antioxidants, 
high oxidative energy requirements, decrease in gene expression of 
key β-cell genes and early apoptosis. Impairment of β-cell functioning 
results in an diminished production of insulin, impairment of glucose-
stimulated insulin secretion, chronic hyperglycemia and eventually the 
development of T2DM and its secondary complications [1].
Despite a vast body of research, the molecular mechanisms underlying 
β-cell dysfunction and early apoptosis in the pathophysiology of 
T2DM remain unclear. Experimental and clinical studies suggest 
that hyperglycemia-induced excessive generation of free radicals 
chiefly contributes to the development as well as the progression of 
diabetes mellitus and its secondary complications [2]. Upon exposure 
to physiological levels of blood glucose, pancreatic β-cells metabolize 
glucose normally, during which production of free radicals remains 
handy. However, in diabetes due to persistent elevation in both fasting 
and postprandial blood glucose levels, the production of free radicals 
remains higher, which chiefly contribute to the primary as well as 
secondary contributions of diabetes mellitus [3,4]. In susceptible 
individuals, hyperglycemia and hyperlipidemia worsen the β-cell 
function by inducing a cascade of processes, respectively, referred to 
as glucotoxicity and lipotoxicity. Chronic hyperglycemia (glucotoxicity), 
chronic dyslipidemia (lipotoxicity), or the combination of both 
(glucolipotoxicity), have been postulated to contribute to the worsening 
of β-cell function over time, creating a cruel cycle by which metabolic 
abnormalities impair insulin secretion, which further aggravates 
metabolic perturbations in diabetes mellitus [5,6].
Oxidative stress results from an imbalance between radical-generating 
and radical-scavenging systems that are increased free radical 
production or reduced activity of antioxidant defenses or both these 
phenomena. In diabetes, protein glycation and glucose autoxidation 
may generate excessive free radicals, which in turn catalyze lipid 
peroxidation [7]. Persistent elevation in glucose levels can stimulate free 
radical production. Weak defense system of the body becomes unable to 
respond the enhanced reactive oxygen species (ROS) generation and as 
a result of an imbalance between ROS and their protection occurs which 
lead to domination of the oxidative stress [8]. Of course, a certain amount 
of ROS is necessary for the normal metabolic processes since ROS play 
various regulatory roles in cells [9]. ROS are produced by neutrophils 
and macrophages during the process of respiratory burst to eliminate 
antigens [10]. ROS also serve as stimulating signals of several genes 
which encode transcription factors, differentiation, and development 
as well as stimulating cell-cell adhesion, cell signaling, involvement in 
vasoregulation, fibroblast proliferation, and increased expression of 
antioxidant enzymes [11,12]. However, detonated production of ROS is 
deleterious. The metabolic abnormalities of diabetes during oxidative 
stress acts as mediators of insulin resistance and its progression to 
glucose intolerance and installation of diabetes mellitus.
Antioxidant defense mechanisms include both enzymatic and non-
enzymatic strategies. Common antioxidants include the vitamins A, C, E 
and the tripeptide glutathione, and the enzymes superoxide dismutase 
(SOD), catalase, glutathione peroxidase (GPx), and glutathione 
reductase (GR) [13]. Antioxidants not only protect against the direct 
injurious effects of oxidants but also alter the inflammatory events that 
play an important role in the pathogenesis of oxidative stress related 
diseases [14].
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Type 2 diabetes is strongly associated with obesity and cardiovascular 
risk. High-fat diet (HFD) fed rats present a metabolic syndrome which is 
characterized by central obesity, insulin resistance, and hyperglycemia 
as well as dyslipidemia which is similar to human metabolic syndrome 
caused by obesity. As the metabolism of carbohydrate and lipid are 
closely linked processes, derangement in the carbohydrate metabolism 
may result in dyslipidemia, hence, HFD fed – low dose streptozotocin 
(STZ) induced model is one of the ideal models for screening of 
antiobesity activity in diabetic rats. Recent reports on the etiology, 
epidemiology, and consequences of T2DM necessitate an urgency to 
find better prognosis, and prevention strategies [15]. Furthermore, STZ 
damages pancreatic β-cells, resulting in hypoinsulinemia and chronic 
hyperglycemia [16].
Various researchers suggest that phytochemicals from traditionally 
known medicinal plants have been extensively used as an alternative 
medicine for the management of diabetes [17]. Most of the antidiabetic 
synthetic drugs in use for long-term therapy have been associated 
with various toxicities owing to which the developmental process in 
antidiabetic drug discovery has shifted its focus toward natural plant 
sources which are having minimal or no side-effects [18]. Some natural 
products have the ability to lower blood glucose and it should be safer 
than allopathic drugs if utilization over a prolonged period. Among the 
natural products, the phenolic compounds are attracting much interest 
because of their beneficial and pharmacological effects on T2DM and its 
secondary complications.
Sinapic acid (3,5-dimethoxy 4-hydroxy cinnamic acid) is a naturally 
occurring carboxylic acid. It is a member of the phenylpropanoid 
family [19]. It is widely distributed in the plant kingdom and is obtained 
from various sources such as rye, mustard, berries, and vegetables [20]. 
Sinapic acid has demonstrated potent antioxidant capacity [21], anti-
inflammatory [22], anxiolytic [23], peroxynitrite scavenging [24], 
neuroprotective [25], and antihyperglycemic properties [26]. Serum 
albumin has been reported to be responsible for the transport of 
sinapic acid in blood due to its ability to bind with serum albumin 
through hydrophobic interaction and hydrogen bonding [27,28]. 
Maximum plasma-sinapic acid level has been described as 40 nM with a 
bioavailability of 3% of the total phenolics present in the non-processed 
cereal meal [29,30]. Moreover, the small intestine was reported as the 
best site for absorption of orally administered sinapic acid through 
active Na+ gradient-driven transport [31]. Plasma sinapic acid level 
has also been quantified (1.5 µg/mL) after intake of cranberry juice in 
human using gas chromatography–mass spectrometry [32]. However, 
metabolism of sinapic acid takes place mainly in the epithelium of 
the small intestine [33]. Recently, we have evaluated the antidiabetic 
properties of sinapic acid in HFD-STZ induced Type 2 diabetic rats.
In the absence of systemic reports in literature regarding the antioxidant 
properties of sinapic acid, the aim of this study is to determine the 
antioxidant properties of sinapic acid both in vitro and in vivo.
METHODS
Experimental animals
Male albino Wistar rats (160-180 g) were purchased from Tamil Nadu 
Veterinary and Animal Sciences University, Chennai. The rats were 
housed in polypropylene cages lined with husk. The rats were fed with 
commercial pellet rats chow (Hindustan Lever Ltd., Bengaluru, India), 
and had free access to water. Rats were maintained in a controlled 
environment (12:12 hrs light/dark cycle and temperature (30±2°C). 
The rats were acclimatized for 1 week before starting the experiments. 
The experiments were designed and conducted in accordance with 
the current ethical norms approved by Ministry of Social Justice and 
Empowerment, Government of India (IAEC No. 05/01/2014).
HFD fed
The rats were divided into four groups each comprising not less than six 
rats and allocated into two dietary regimens by feeding either normal 
or HFD for the initial period of 2 weeks. The ingredients and chemical 
composition of the HFD were followed as before reported [34]. After 
2 weeks of dietary manipulation for the onset of insulin resistance, the 
groups of rats fed with HFD were injected intraperitoneally with a low 
dose of STZ (35 mg/kg b.w.) dissolved in freshly prepared 0.1 M cold 
citrate buffer, pH 4.5. 1 week after STZ injection, the rats were screened 
for blood glucose level. Rats are having fasting blood glucose 
>250 mg/dl that exhibited random hyperglycemia and glycosuria were 
selected for the experiment. The rats were allowed to continue to feed 
on the respective diets until the end of the experiments.
Experimental design
The rats were divided into four groups each group comprising six rats.
• Group 1: Control rats
• Group 2: Diabetic rats (HFD-low dose STZ (35 mg/kg body weight 
[bw])
• Group 3: Diabetic rats treated with sinapic acid (25 mg/kg bw)
• Group4: Diabetic rats treated with metformin (50 mg/kg bw).
Sinapic acid was dissolved in 0.2% dimethyl sulfoxide and administrated 
to rats orally using an intragastric tube daily for a period of 30 days.
Sample collection
After 30 days of the experimental period, the animals were fasted 
overnight and then sacrificed by cervical decapitation. Blood was 
collected, and serum was separated by centrifugation. The pancreas, 
liver, and kidney were carefully removed, weighed and washed in ice-
cold saline. The tissues were sliced into pieces and homogenized in 
an appropriate buffer (pH 7.0). The homogenates were centrifuged at 
3000 rpm for 10 min at 0°C in cold centrifuge. The supernatant was 
separated and used for various biochemical estimations.
Assay of antioxidant status
In vitro antioxidant assays
1,1-diphenyl-2-picrylhydrazyl (DPPH) assay
The DPPH radical scavenging activity of sinapic acid was determined 
by the method of Brand-Williams et al. with some modifications [35]. 
The methanolic solution of DPPH (60 µM) was mixed with an equivalent 
aliquot of different concentration (3.125-100 µM) of sinapic acid in 
methanol. The absorbance was determined at 515 nm after 2 minutes 
incubation in the dark, spectrophotometrically.
2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay
ABTS radical scavenging activity of sinapic acid was determined 
according to the method of Re et al., (1999) [36]. Briefly, ABTS radical 
cation was produced by mixing ABTS stock solution (7 mM in water) 
with 2.45 mM potassium persulfate and allowing the mixture to stand 
in the dark at room temperature for 12-16 hrs before use. Then, ABTS 
radical solution was diluted with ethanol to an absorbance of 0.7 at 
734 nm. To 3.0 ml of diluted ABTS radical solution, 30 µl of different 
concentration (3.125-100 µM) of sinapic acid in ethanol was added and 
after 1 minute, the decrease in absorbance was measured at 734 nm 
spectrophotometrically.
Superoxide anion radical scavenging assay
The superoxide radical scavenging activity of sinapic acid was 
measured by the method of Fontana et al., (2001) [37]. In this method, 
the activity is measured by reduction of riboflavin/light/nitro blue 
tetrazolium (NBT). The 1 ml of reaction mixture contained phosphate 
buffer, nicotinamide adenine dinucleotide (NADH), NBT and various 
concentrations of the sample solution. The method is based on the 
generation of superoxide radical by autoxidation of riboflavin in the 
presence of light. The superoxide radical reduces NBT to a blue colored 
formazan that can be measured at 560 nm.
Assay for nitric oxide (NO) scavenging activity
Sodium nitroprusside (5 mM) in phosphate buffer with pH 7.7 was 
incubated with 3.125-100 µM concentrations of drug dissolved 
in a suitable solvent (alcohol), and tubes were incubated at 25°C 
for 120 minutes. At intervals, 0.5 ml of incubation solution was 
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removed and diluted with 0.5 ml of Griess reagent. The absorbance 
of the chromophore formed during diazotization of nitrite with 
sulphanilamide and subsequent N-naphthyl ethylenediamine was 
measured at 546 nm [38].
In vivo antioxidant assay
Assay of antioxidant status
The levels of lipid peroxides and hydroperoxides were determined in 
plasma and tissue homogenates [39-41]. The activities of enzymatic 
antioxidants such as SOD [42], catalase [43], GPx [44], glutathione-
S-transferase (GST) [45], and GR [46] were assayed in the tissue 
homogenates of control and experimental groups of rats. The levels of 
non-enzymatic antioxidants such as vitamin C, vitamin E, ceruloplasmin, 
and glutathione (GSH) were also determined [47-50].
Statistical analysis
The results were expressed as mean±standard error of mean of six 
rats per group, and statistical significance was evaluated by one-way 
analysis of variance using SPSS (version 16) program followed by 
the least significant difference. Values were considered statistically 
significant when p<0.05.
RESULTS
Figs. 1 and 2 depict the dose-dependent effect of sinapic acid on the 
percentage inhibition of DPPH and ABTS radicals present in the 
reaction mixtures. Sinapic acid scavenges both DPPH and ABTS radicals 
in a concentration-dependent manner. However, at a concentration 
of 100 µg/ml, sinapic acid significantly scavenged 82% of DPPH and 
86.5% ABTS radicals. Superoxide and NO scavenging potential of the 
sinapic acid are presented in Figs. 3 and 4, respectively. Sinapic acid 
Fig. 1: In vitro 1,1-diphenyl-2-picrylhydrazyl radical scavenging 
effect of sinapic acid
Fig. 2: 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
radical scavenging effect of sinapic acid
Fig. 3: Superoxide radical scavenging effect of sinapic acid
Fig. 4: Nitric oxide radical scavenging effect of sinapic acid
exhibited a maximum of 88.6% superoxide scavenging activity and 78% 
NO scavenging potential.
Tables 1-4 exemplify the levels of TBARS, hydroperoxides and protein 
carbonyls in plasma, pancreatic, hepatic and renal tissues of control and 
experimental groups of rats. The significant (p<0.05) increase noted on 
the levels of these oxidative stress markers in plasma as well as in the 
tissues of diabetic group of rats were declined (p<0.05) significantly 
to near normalcy by sinapic acid as well as metformin treatment to 
diabetic groups of rats.
The activities of enzymatic antioxidants such as SOD, CAT, GPx and 
GST (Tables 5-7) in the pancreatic, hepatic, and renal tissues were 
significantly improved in sinapic acid treated diabetic rats indicating 
the antioxidant potential of sinapic acid. Furthermore, the plasma levels 
of non-enzymatic antioxidants such as vitamin C, vitamin E, reduced 
glutathione and ceruloplasmin (Table 8), and hepatic as well as renal 
GSH (Table 9) content were found to be increased on oral treatment 
with sinapic acid.
DISCUSSION
Antioxidants derived from medicinal plants provide protection to 
cells by scavenging the excessive free radicals through offsetting ROS. 
This has been made possible due to the presence of certain bioactive 
substances, such as phenolic compounds, flavonoids and essential oils, 
and rendering plants with antioxidant activity [51].
In vitro antioxidant potential
The DPPH and ABTS radicals scavenging activity of sinapic acid 
is depicted in Figs. 1 and 2, respectively. DPPH radical scavenging 
activity was quantified in terms of percentage inhibition of a 
pre-formed free radical by antioxidants. There was a significant 
improvement in the percentage inhibition of the DPPH radicals 
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by sinapic acid. ABTS radical activity was quantified in terms of 
percentage inhibition of the ABTS radical cation by antioxidants in 
each sample sinapic acid showed 82% inhibition at a concentration 
of 50 µM in DPPH assay and 86.5% inhibition at a concentration 
of 50 µM in ABTS radical assay reflecting its radical scavenging 
capacity.
Table 4: Effect of sinapic acid treatment on the levels of lipid peroxides, hydroperoxides, and protein carbonyls in renal tissues of control 
and experimental groups of rats
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 1.05±0.073 50.10±3.18 3.75±0.30
Diabetic control 3.40±0.20a* 85.50±3.80a* 17.47±0.89a*
Diabetic+sinapic acid 2.18±0.13a*b*c 59.28±3.58ab*c 9.11±0.55a*b*
Diabetic+metformin 1.98±0.12a*b* 60.11±4.40ab* 7.24±0.48a*b*c@
Units are expressed as mM/100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls. Values are given as mean±SEM for 
groups of six rats in each. One-way ANOVA followed by post hoc test LSD. Statistical significance was compared within the groups as follows: aControl rats; bDiabetic 
control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. SEM: Standard error of mean, LSD: Least square 
difference
Table 5: Activities of SOD, CAT, GPx, and GST in pancreatic tissues of control and experimental groups of rats.
Groups SOD CAT GPx GST
Control 5.57±0.32 25.00±2.20 6.81±0.31 5.91±0.29
Diabetic 3.20±0.22a* 6.63±0.42a* 3.10±0.24a* 2.00±0.31a*
Diabetic+sinapic acid 4.44±0.20a*b*c 13.40±0.69a*b#c 5.59±0.34a@b*c 4.50±0.24a*b*c
Diabetic+metformin 4.91±0.33a*b* 15.42±0.73a*b# 6.13±0.34ab* 4.99±0.31a*b*
Activities of enzymes are expressed as 50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein 
for catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST. Values are given as mean±SEM for groups of six rats in each. 
One-way ANOVA followed by post-hoc test LSD. Statistical significance was compared within the groups as follows: aControl rats; bDiabetic control rats; cDiabetic rats 
treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. SOD: Superoxide dismutase, CAT: Catalase, GPx: Glutathione peroxidase, 
GST: Glutathione-S-transferase 
Table 1: The levels of lipid peroxides, hydroperoxides and protein carbonyls in plasma of control and experimental groups of rats after 
30 days of experimental period
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 3.60±0.22 9.9±0.50 6.50±0.33
Diabetic control 10.2±0.33a* 27.30±2.15a* 26.53±2.00a*
Diabetic+sinapic acid 4.45±0.28ab*c 17.80±1.50a#b*c 14.44±0.83a*b*c
Diabetic+metformin 4.61±0.25a#b* 15.61±1.12a*b# 14.00±0.91a#b*
Units are expressed as nM/ml for lipid peroxides; 10-5 mM/dl for hydroperoxides; nM/mg of protein for protein carbonyls. Values are given as mean±SEM for groups of 
six rats in each. One-way ANOVA followed by post hoc test LSD. Statistical significance was compared within the groups as follows: aControl rats; bDiabetic control rats; 
cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. SEM: Standard error of mean, LSD: Least square difference
Table 2: Effect of sinapic acid treatment on the levels of lipid peroxides, hydroperoxides, and protein carbonyls in pancreatic tissues of 
experimental groups of rats
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 37.33±2.40 14.10±0.88 5.18±0.25
Diabetic control 65.21±4.33a* 32.04±1.71a* 20.10±1.13a*
Diabetic+sinapic acid 40.00±2.40ab*c 17.32±1.15ab*c 11.21±0.58a*b*c
Diabetic+metformin 38.30±3.00a@b* 15.02±0.71ab* 10.88±0.62a*b*
Units are expressed as mM/100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls. Values are given as mean±SEM for 
groups of six rats in each. One-way ANOVA followed by post hoc test LSD. Statistical significance was compared within the groups as follows: aControl rats; bDiabetic 
control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. SEM: Standard error of mean, LSD: Least square 
difference
Table 3: Effect of sinapic acid treatment on the levels of lipid peroxides, hydroperoxides, and protein carbonyls in hepatic tissues of 
control and experimental groups of rats
Groups Lipid peroxides Hydroperoxides Protein carbonyls
Control 1.37±0.12 47.42±4.09 4.51±0.32
Diabetic control 4.41±0.25a* 127.10±7.03a* 14.20±0.76a*
Diabetic+sinapic acid 2.36±0.17a#b*c 81.74±4.02a*b*c 7.15±0.29a*b*c
Diabetic+metformin 2.88±0.21a*b* 71.41±3.12a*b* 7.53±0.32a*b*
Units are expressed as mM/100 g of wet tissue for lipid peroxides and hydroperoxides; nM/mg of protein for protein carbonyls. Values are given as mean±SEM for 
groups of six rats in each. One-way ANOVA followed by post hoc test LSD. Statistical significance was compared within the groups as follows: aControl rats; bDiabetic 
control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. SEM: Standard error of mean, LSD: Least square 
difference
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Among, the several in vitro antioxidant assays, DPPH and ABTS 
radical assay have been widely used as more convenient methods 
in determining the free radical scavenging efficacy of the lead 
molecules [52,53]. The antiradical activity assay is based on the 
reduction of DPPH in methanolic solution. Due to the presence of an 
odd electron, DPPH gives a strong absorption maximum at 517 nm. As 
this electron becomes paired off in the presence of a hydrogen donor, 
i.e., a free radical scavenging antioxidant, the absorption strength is 
decreased, and the resulting decolorization is stoichiometric with 
respect to the number of electrons captured.
ABTS radicals are more reactive than DPPH radicals and the reaction 
with ABTS radicals involve a single electron transfer process. The 
principle lying behind the ABTS radical assay is the pre-formed 
radical monocation of ABTS radical which is generated by oxidation of 
ABTSradicals with potassium persulfate and is reduced in the presence 
of such hydrogen-donating antioxidants. The antioxidant activity of 
different flavonoids depends on the number and location of hydroxyl 
groups of the flavonoid ring system [54]. Sinapic acid showed 86.5% 
inhibition at a concentration of 50 µM in ABTS radical assay which 
exemplifies its significant radical scavenging capacity. The results 
of DPPH and ABTS radical scavenging assay imply the free radical 
scavenging property of sinapic acid which was comparable with the 
efficacy of metformin.
The primary free radical in most biological systems is superoxide (O2•−). 
Although O2•− itself is quite uncreative compared to the other radicals, 
it can be decomposed to form stronger oxidative species such as singlet 
oxygen and hydroxyl radicals. From the investigations, it was found 
that sinapic acid scavenged O2•− significantly and in a concentration-
dependent manner. The O2•− scavenging activity was determined by 
phenazine methosulfate/NADH-NBT system wherein O2•− derived from 
dissolved oxygen by phenazine methosulfate/NADH coupling reaction 
reduces NBT. The decrease in absorbance at 560 nm with antioxidants 
thus indicates the consumption of superoxide anions in the reaction 
mixture. Sinapic acid exhibited a maximum of 88.6% superoxide 
Table 6: Activities of SOD, CAT, GPx, GST, and GR in hepatic tissues of control and experimental groups of rats
Groups SOD CAT GPx GST GR
Control 11.55±0.62 80.10±3.11 10.52±0.49 8.09±0.46 28.30±2.74
Diabetic 4.65±0.23a* 38.50±2.48a* 4.68±0.18a* 3.60±0.18a* 12.60±0.68a*
Diabetic+sinapic acid 7.82±0.24a*b*c 67.10±2.44a#b*c 7.20±0.36a*b*c 6.43±0.28a#b*c 22.33±1.75a@b#c
Diabetic+metformin 7.20±0.27a*b* 70.81±3.05a*b* 8.00±0.23a*b* 7.00±0.29a#b* 23.50±2.00ab*
Activities of enzymes are expressed as 50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein for 
catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST; µM of DTNB-GSH conjugate formed/min/mg of protein for GR. Values 
are given as mean±SEM for groups of six rats in each. One-way ANOVA followed by post-hoc test LSD. Statistical significance was compared within the groups as follows: 
aControl rats; bDiabetic control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001. GR: Glutathione reductase
Table 7: Activities of SOD, CAT, GPx, GST, and GR in renal tissues of control and experimental groups of rats
Groups SOD Catalase GPx GST GR
Control 17.20±0.93 44.34±3.01 8.0±0.24 6.40±0.16 33.11±2.00
Diabetic 8.23±0.51a* 17.10±1.11a* 3.66±0.21a* 2.42±0.16a* 11.40±0.72a*
Diabetic+sinapic acid 14.08±0.58a@b*c 29.01±1.74a*b*c 6.50±0.23a*b*c 4.32±0.25a*b*c 26.51±1.78a@b*c
Diabetic+metformin 13.39±0.45a#b* 30.64±2.27a*b# 7.10±0.21a*b* 5.01±0.30a*b* 27.55±1.31a*b*
Activities of enzymes are expressed as: 50% of inhibition of epinephrine autoxidation/min for SOD; mM of hydrogen peroxide decomposed/min/mg of protein for 
catalase; mM of glutathione oxidized/min/mg of protein for GPx; U/min/mg of protein for GST; µM of DTNB-GSH conjugate formed/min/mg of protein for GR. Values 
are given as mean±SEM for groups of six rats in each. One-way ANOVA followed by post-hoc test LSD. Statistical significance was compared within the groups as follows: 
aControl rats; bDiabetic control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001




Control 22.44±1.22 48.10±2.67 36.40±1.91
Diabetic 9.04±0.42a* 23.41±1.19a* 21.03±0.78a*
Diabetic+sinapic acid 14.92±0.42a*b*c 38.30±2.70a#b*c 28.10±1.58a*b#c
Diabetic+metformin 17.00±0.99a*b* 40.10±2.01a#b* 30.27±1.18a@b*
Units: mg/100 g of wet tissue. Values are given as mean±S.E.M for groups of six rats in each. One-way ANOVA followed by post-hoc test LSD. Statistical significance 
was compared within the groups as follows: aControl rats; bDiabetic control rats; cDiabetic rats treated with metformin. Values are statistically significant 
at @p<0.05; #p<0.01; *p<0.001
Table 8: Effect of sinapic acid on the levels of vitamin E, vitamin C, ceruloplasmin, and reduced glutathione in plasma of control and 
experimental groups of rats
Groups Vitamin E Vitamin C Ceruloplasmin GSH
Control 1.00±0.06 1.53±0.080 14.00±0.13 38.81±2.48
Diabetic 0.40±0.031a* 0.46±0.048a* 5.00±0.32a* 17.00±1.12a*
Diabetic+sinapic acid 0.81±0.052ab*c 0.94±0.073a*b*c 10.11±0.56a*b*c 27.41±1.91a#b*c
Diabetic+metformin 0.86±0.04a*b# 1.00±0.043a*b# 11.08±0.45a*b* 29.33±1.28a*b*
Units: mg/dl. Values are given as mean±SEM for groups of six rats in each. One-way ANOVA followed by post-hoc test LSD. Statistical significance was compared within 
the groups as follows: aControl rats; bDiabetic control rats; cDiabetic rats treated with metformin. Values are statistically significant at @p<0.05; #p<0.01; *p<0.001
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scavenging activity (Fig. 3) with a significant extent at a concentration 
of 50 µM. Sinapic acid at a concentration of 50 µM also quenched 78% 
NO radical (Fig. 4).
NO acts as neurotransmitter through exerting its effect on different 
body operations, such as neurotransmission, synaptic plasticity, 
vasodilation, and CNS memory [55,56]. Besides key role of NO in 
facilitating normal function, it has been observed that NO has been 
associated with pathophysiological states such as neurodegenerative 
and Alzheimer’s disease. Excessive release of NO in the body can 
cause DNA fragmentation, cell damage and neuronal cell death [57]. 
Phytochemicals can play a crucial role in reducing the amount of NO 
through their efficient NO scavenging activity.
Kikuzaki et al. [21] have reported that sinapic acid possess significant 
inhibitory activity of 33.2% of the DPPH radical at the concentration 
of 20 µM. A 0.5 molar ratio of sinapic acid inhibits 88.4% of the DPPH 
radical [58]. According to Hotta et al., [59] the concentration of sinapic 
acid that reduced 50% of DPPH radical concentration inhibitory 
concentration 50% was 0.3 mM for sinapic acid. Sinapic acid has 55.42% 
of ABTS radical inhibiting activity at the concentration of 10-50 µM. 
Superoxide radical scavenging activity inhibition was 35.52% using 
0.05 mM of sinapic acid [60]. Masek et al. [61] have reported that 
sinapic acid showed 39.4% inhibition activity at 5-30 µg/ml. Thus, the 
results of this study are on par with the earlier reports indicating that 
sinapic acid effectively scavenges the free radicals.
In vivo antioxidant potential
Persistent hyperglycemia results in the increased formation of 
advanced glycation end and lipid peroxidation products that 
exacerbate intracellular oxidative stress, resulting in a loss of molecular 
integrity, disruption in cellular signaling and homeostasis, followed 
by inflammation and tissue injury. Having evolved in an oxygen 
environment, most cells, including pancreatic β-cells, have acquired 
intricate mechanisms to defend against ROS toxicity. Antioxidants are 
considered important nutraceuticals on account of their many health 
benefits and widely used in the food industry as potential inhibitors 
of lipid peroxidation. It is generally accepted that the consumption of 
plant foods is associated with a lower risk of development of oxidative 
stress-mediated diseases [62]. Polyphenols represent one of the largest 
chemical entities in the plant kingdom, gathered into four main classes 
such as phenolic acids, flavonoids, stilbenes, and lignans [63]. In recent 
times, polyphenolic compounds have attracted great attention and have 
been subject to broad research primarily because of their antioxidant 
properties and beneficial health effects resulting from them [64].
Oxidative stress is associated with oxidative modification of biomolecules 
which are involved in a number of pathophysiological processes such 
as aging, diabetes, atherosclerosis, inflammation, and carcinogenesis. 
Lipid peroxidation is a free radical process involving a source of 
secondary free radical, which further can act as the second messenger 
or can directly react with other biomolecules, enhancing biochemical 
lesions. Lipid peroxidation primarily occurs on polyunsaturated fatty 
acids located on the cell membranes and it further proceeds with 
a radical chain reaction. Hydroxyl radical is thought to initiate ROS 
and remove hydrogen atom, thus producing lipid radical and further 
converted into diene conjugate. Further, by the addition of oxygen, it 
forms peroxyl radical; this highly reactive radical attacks another fatty 
acid forming lipid hydroperoxide (LOOH) and a new radical. Thus, 
lipid peroxidation is propagated. Due to lipid peroxidation, a number 
of compounds such as alkanes, malanoaldehyde, and isoprotanes are 
formed. These compounds are used as markers in lipid peroxidation 
assay and have been verified in many diseases such as neurogenerative 
diseases, ischemic reperfusion injury, and diabetes.
The elevated cytotoxic and highly reactive oxidative stress markers 
such as lipid peroxides and hydroperoxides causes oxidative damage 
to proteins as well as DNA and the reduced cellular non-enzymatic and 
enzymatic antioxidant levels in diabetic conditions further increases 
the severity of tissue dysfunction resulting in decreased insulin 
synthesis, secretion and finally resulting in β-cell death. In this study, 
the elevated levels of lipid peroxides and hydroperoxides in plasma, 
pancreatic, hepatic, and renal tissues of diabetic rats were significantly 
altered on oral administration of sinapic acid which demonstrates the 
anti-lipid peroxidative property of sinapic acid under oxidative stress 
environment.
Cells are protected against oxidative stress by an interacting network 
of antioxidant enzymes [65]. Superoxide released by processes such 
as oxidative phosphorylation is converted to hydrogen peroxide and 
further reduced to water. This detoxification pathway is the result of 
multiple enzymes, with SODs catalyzing the first step and then catalases 
and various peroxidases removing hydrogen peroxide [66].
SODs are a class of closely related enzymes that catalyze the breakdown 
of superoxide anion into oxygen and hydrogen peroxide [67]. SOD 
enzymes are present in almost all aerobic cells and in extracellular 
fluids [68]. Catalase is a common enzyme found in nearly all living 
organisms, which are exposed to oxygen, where it functions to catalyze 
the decomposition of hydrogen peroxide to water and oxygen [69]. 
Hydrogen peroxide is a harmful by-product of many normal metabolic 
processes: To prevent damage, it must be quickly converted into other 
less dangerous substances. To this end, catalase is frequently used by 
cells to rapidly catalyze the decomposition of hydrogen peroxide into 
less reactive gaseous oxygen and water molecules [70].
The glutathione system includes glutathione, GR, GPx, and GST. This 
system is found in animals, plants, and microorganisms [71]. GPx 
is an enzyme containing four selenium-cofactors that catalyze the 
breakdown of hydrogen peroxide and organic hydroperoxides. There 
are at least four different GPx isozymes in animals [72]. The GSTs show 
high activity with lipid peroxides. These enzymes are at particularly 
high levels in the liver and also serve in detoxification metabolism [73]. 
The activities of enzymatic antioxidants such as SOD, CAT, GPx, and GST 
in the pancreatic, hepatic and renal tissues were significantly improved 
in sinapic acid treated diabetic rats indicating the antioxidant potential 
of sinapic acid.
Reduced glutathione, a ubiquitous tripeptide thiol, is an important 
intracellular metabolite. It acts as an antioxidant and provides 
secondary line of defense against intracellular free radicals and 
peroxides generated by oxidative stress. Reduced state of the cell is 
maintained by high level of GSH/GSSG ratio. When the level of GSSG, the 
oxidized form of GSH increased in the presence of persistently elevated 
ROS, then the redox state of cell get affected, and it may result in the 
development of diabetic complications. Measurement of intracellular 
GSH/GSSG ratio may provide valuable information about the redox 
status of the cell.
Ascorbic acid or “vitamin C” is a monosaccharide antioxidant found in 
both animals and plants. As it cannot be synthesized in humans and 
must be obtained from the diet. Most other animals are able to produce 
this compound in their bodies and do not require it in their diets. In 
cells, ascorbic acid is maintained in its reduced form by reaction with 
glutathione, which can be catalyzed by protein disulfide isomerase and 
glutaredoxins [74]. Ascorbic acid is a reducing agent capable of reduce 
and thereby neutralize ROS such as hydrogen peroxide [75].
Glutathione is a cysteine-containing peptide found in most forms of 
aerobic life. It is not required in the diet and is instead synthesized 
in cells from its constituent amino acids. Glutathione has antioxidant 
properties since the thiol group in its cysteine moiety is a reducing 
agent and can be reversibly oxidized and reduced. In cells, glutathione is 
maintained in the reduced form by the enzyme GR and in turn reduces 
other metabolites and enzyme systems as well as reacting directly with 
oxidants. Due to its high concentration and central role in maintaining 
the cell’s redox state, glutathione is one of the most important cellular 
antioxidants.
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Vitamin E is the collective name for a set of eight related tocopherols 
and tocotrienols, which are fat-soluble vitamins with antioxidant 
properties [76]. It has been claimed that the α-tocopherol form is 
the most important lipid-soluble antioxidant and that it protects 
membranes from oxidation by reacting with lipid radicals produced in 
the lipid peroxidation chain reaction [77]. This removes the free radical 
intermediates and prevents the propagation reaction from continuing. 
This reaction produces oxidized α-tocopheroxyl radicals that can be 
recycled back to the active reduced form through reduction by other 
antioxidants, such as ascorbate, retinol, or ubiquinol [78].
The plasma levels of non-enzymatic antioxidants such as vitamin C, 
vitamin E, reduced glutathione and ceruloplasmin and hepatic and 
renal GSH content were found to be increased on sinapic acid treatment. 
The observed improvement in the antioxidant status reflects the 
antioxidant property of sinapic acid. Free radicals damage contributes 
to the etiology of many chronic health problems such as cardiovascular 
and inflammatory diseases, cataract and cancer. Antioxidants prevent 
free radical induced tissue damage by preventing the formation of 
radicals, scavenging them, or by promoting their decomposition. 
Studies indicate that nutrition plays a crucial role in the prevention of 
chronic diseases, as most of them can be related to diet.
CONCLUSION
The results of this study evidenced that sinapic acid possess significant 
antioxidant property in addition to its antidiabetic activity. The 
improved antioxidant status and declined oxidative stress markers in 
plasma and tissues effectively illustrate the antioxidant potential of 
sinapic acid. The study also portrays the protective nature of sinapic 
acid against hyperglycemia-mediated oxidative stress in experimental 
Type 2 diabetes in rats.
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